| Literature DB >> 31165612 |
Rezan Aksoy1, Taylan Adademir1, Ekrem Yilmaz1, Deniz Cevirme1, Mehmet Sengor1, Cengiz Koksal2, Murat Bulent Rabus1.
Abstract
OBJECTIVE: Acute kidney injury (AKI) is one of the most important complications after coronary artery bypass grafting (CABG) procedure. Serum albumin, which is an acute phase reactant, is suggested to be associated with AKI development subsequent to various surgical procedures. In this study, we research the relation between preoperative serum albumin levels and postoperative AKI development in diabetes mellitus (DM) patients undergoing isolated CABG.Entities:
Keywords: Coronary Bypass; Diabetes Mellitus; Hypoalbuminemia
Mesh:
Substances:
Year: 2019 PMID: 31165612 PMCID: PMC6852450 DOI: 10.21470/1678-9741-2018-0291
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Baseline characteristics of the study subjects.
| AKI (n=230) | Non-AKI (n=404) | |||
|---|---|---|---|---|
| Preoperative data | Male % (N) | 58.6 (135) | 68.8 (278) | 0.010 |
| Age (years) | 61.8±9.1 | 59.7±9 | 0.005 | |
| BMI | 30.5±5.7 | 29.2±4.8 | 0.007 | |
| Hypertension | 51.7 (209) | 41.8 (138) | <0.001 | |
| Previous MI | 7.4 (17) | 7.6 (31) | 0.495 | |
| Previous cardiac surgery | 1.3 (3) | 2.5 (10) | 0.379 | |
| Fasting blood glucose (mg/dl) | 182±59 | 171±54 | 0.023 | |
| Proteinuria (mg) | 15.2 (35) | 12.5 (38) | 0.004 | |
| Creatinine (mg/dL) | 1.2±0.89 | 0.95±0.33 | <0.001 | |
| Hemoglobin (g/dL) | 12.2±1.7 | 13.0±1.7 | <0.001 | |
| RDW (%) | 15.1±1.7 | 14.5±1.7 | <0.001 | |
| Albumin (g/dL) | 3.96±0.47 | 4.1±0.48 | <0.001 | |
| Uric acid (mg/dL) | 5.9±2 | 5.3±1.7 | 0.002 | |
| C-reactive protein (mg/L) | 1.54±2 | 1.61±2.9 | 0.742 | |
| LVEF (%) | 52.6±12.3 | 53.9±11.6 | 0.267 | |
| Intra-operative data | Drainage (mL) | 550 (350-800) | 600 (450-800) | 0.317 |
| Intubation time (hour) | 13 (10-19) | 10 (8-13) | <0.001 | |
| ACC time (minutes) | 54 (32-82) | 48.5 (33-70) | 0.024 | |
| CPB | 89.5 | 87.3 | 0.412 | |
| Post-operative data | ICU stay (days) | 70 (39-121) | 55 (24-71) | <0.001 |
| Creatinine, first day (mg/dL) | 1.6±1 | 0.95±0.31 | <0.001 | |
| Creatinine, second day (mg/dL) | 1.67±1 | 0.88±0.30 | <0.001 | |
| Creatinine, third day (mg/dL) | 1.71±1.2 | 0.90±0.34 | <0.001 | |
ACC=aortic cross-clamping; AKI=acute kidney injury; BMI=body mass index; CPB=cardiopulmonary bypass; ICU=intensive care unit; LVEF=left ventricular ejection fraction; MI=myocardial infarction; RDW=red cell distribution width
Multivariate predictors for acute kidney injury after coronary artery bypass grafting.
| Univariate OR, 95% CI | Multivariate OR, 95% CI | |||
|---|---|---|---|---|
| Male (N) | 0.644(0.460-0.902) | 0.010 | 0.572(0.288-1.137) | 0.111 |
| Age (years) | 1.026(1.008-1.045) | 0.005 | 1.006(0.971-1.043) | 0.725 |
| Preoperative Hgb (g/dL) | 0.760(0.687-0.841) | <0.001 | 1.111(0.882-1.400) | 0.370 |
| Preoperative RDW (%) | 1.218(1.106-1.342) | <0.001 | 1.045(0.862-1.266) | 0.657 |
| Baseline creatinine (mg/dL) | 2.260(1.560-3.273) | <0.001 | 1.150(0.609-2.172) | 0.665 |
| Preop uric acid(mg/dL) | 1.189(1.065-1.328) | 0.002 | 1.086(0.918-1.284) | 0.336 |
| ACC time (minutes) | 1.006(1.001-1.012) | 0.024 | 1.001(0.993-1.009) | 0.847 |
ACC=aortic cross-clamping; BMI=body mass index; CI=confidence interval; Hgb=hemoglobin; OR=odds ratio; RDW=red cell distribution width
Fig. 1Preoperative serum albumin according to the acute kidney injury (AKI) stage. CI=confidence interval; KDIGO=Kidney Disease: Improving Global Outcomes
Fig. 2Receiver operating characteristic (ROC) curve plot for preoperative serum albumin in prediction of acute kidney injury (AKI). AUC=area under the curve
Fig. 3Estimated marginal means of creatinine. AKI=acute kidney injury
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| ACC | = Aortic cross-clamping | Hgb | = Hemoglobin | |
| AKI | = Acute kidney injury | HT | = Hypertension | |
| ANOVA | = Analysis of variance | ICU | = Intensive care unit | |
| AUC | = Area under the curve | IQR | = Interquartile range | |
| BMI | = Body mass index | KDIGO | = Kidney Disease: Improving Global Outcomes | |
| CABG | = Coronary artery bypass grafting | LVEF | = Left ventricular ejection fraction | |
| CI | = Confidence interval | MI | = Myocardial infarction | |
| CPB | = Cardiopulmonary bypass | OR | = Odds ratio | |
| CRP | = C-reactive protein | RDW | = Red cell distribution width | |
| DM | = Diabetic mellitus | ROC | = Receiver operating characteristic | |
| EDTA | = Ethylenediaminetetraacetic acid | SD | = Standard deviation | |
| EF | = Ejection fraction | SCr | = Serum creatinine | |
| GFR | = Glomerular filtration rate | SPSS | = Statistical Package for Social Sciences | |
| Authors' roles & responsibilities | |
|---|---|
| RA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| TA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| EY | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| DC | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| MS | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| CK | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| MBR | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |